Company Encyclopedia
View More
name
RPC
000650.SZ
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is based in Nanchang, China.
3.157 T
000650.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking114/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.15%B
    • Profit Margin11.85%B
    • Gross Margin36.30%C
  • Growth ScoreD
    • Revenue YoY-13.89%E
    • Net Profit YoY0.63%C
    • Total Assets YoY6.13%B
    • Net Assets YoY2.87%C
  • Cash ScoreC
    • Cash Flow Margin843.73%B
    • OCF YoY-13.89%E
  • Operating ScoreC
    • Turnover0.48C
  • Debt ScoreA
    • Gearing Ratio13.08%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    RPC released its performance for the first three quarters, with a net profit attributable to the parent company of 379 million yuan, a year-on-year decrease of 8.79%

    According to the Zhitong Finance APP, RPC released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 2.833 billion yuan, a year-on-year decrease of 10.07%. The net profit attributable to shareholders of the listed company was 379 million yuan, a year-on-year decrease of 8.79%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 277 million yuan, a year-on-year decrease of 8.59%

    Zhitong·
    SZ
    000650
    +0.50%
    Zhitong·
    SZ
    000650
    +0.50%

    Renhe partners with IVD MEDICAL: Which listed company will rush in and be the first to slice the big cake of RWA?

    RPC has reached a strategic cooperation with IVD MEDICAL to jointly establish the world's first over-the-counter drug RWA exchange, and the market response has been positive. RPC's stock price rose by 5.49%, while IVD MEDICAL's stock price reversed and increased by 3.27%. The RWA market is expected to reach USD 16 trillion by 2030, with many listed companies actively positioning themselves, reflecting both anticipation and caution towards this emerging market

    Zhitong·
    HK
    01931
    -0.88%
    SZ
    000650
    +0.50%
    Zhitong·
    HK
    01931
    -0.88%
    SZ
    000650
    +0.50%

    RPC: The company's Ulook glasses have not yet been officially released

    On September 2nd, RPC stated on the interactive platform that the company's Ulook glasses have not yet been officially released

    Zhitong·
    SZ
    000650
    +0.50%
    Zhitong·
    SZ
    000650
    +0.50%

    RPC released its performance for the first half of the year, with a net profit attributable to the parent company of 290 million yuan, a decrease of 13.87%

    According to the Zhitong Finance APP, RPC released its semi-annual report for 2025, showing that the company's operating revenue was 1.975 billion yuan, a year-on-year decrease of 16.46%. The net profit attributable to shareholders of the listed company was 290 million yuan, a year-on-year decrease of 13.87%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 207 million yuan, a year-on-year decrease of 17.88%. The basic earnings per share were 0.2075 yuan

    Zhitong·
    SZ
    000650
    +0.50%
    Zhitong·
    SZ
    000650
    +0.50%

    Actively rewarding investors, multiple companies plan interim dividends

    Recently, several companies such as RPC and JJ SHIPPING have announced their annual equity distribution plans for 2024. A total of 1,532 listed companies in the A-share market have completed their dividend plans. Companies like Haibo Sichuang and Livzon Pharmaceutical Group are among those proposing significant dividend amounts. In addition, multiple listed companies have also announced their interim dividend plans

    Wallstreetcn·
    SH
    601083
    +0.09%
    SZ
    000650
    +0.50%
    Wallstreetcn·
    SH
    601083
    +0.09%
    SZ
    000650
    +0.50%
    © 2025 Longbridge｜Disclaimer